<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0">
<channel>
<title>Chinese Journal of Magnetic Resonance Imaging RSS feed</title>
<link>http://med-sci.cn/cgzcx/en/contents_list.asp?issue=202507</link>
<language>zh-cn</language>
<copyright>An RSS feed for Chinese Journal of Magnetic Resonance Imaging</copyright>
<item>
<title><![CDATA[Regulatory effect of gut-targeted therapy on brain function and emotional changes in patients with diarrhea-predominant irritable bowel syndrome: A resting-state fMRI study]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.07.001</link>
<description><![CDATA[<b>Objective</b>To investigate changes in brain functional activity before and after gut-targeted therapy in patients with diarrhea-predominant irritable bowel syndrome (IBS-D) using resting-state functional magnetic resonance imaging (rs-fMRI), and to explore the underlying gut-brain regulatory mechanisms. <b>Materials and Methods</b>Thirty newly diagnosed IBS-D patients (meeting Rome Ⅳ criteria) were prospectively enrolled. Baseline assessments included the Irritable Bowel Syndrome Symptom Severity Scale (IBS-SSS), Hamilton Anxiety Scale (HAMA), Hamilton Depression Scale (HAMD), and Pittsburgh Sleep Quality Index (PSQI), followed by rs-fMRI scanning. After 30 days of standardized gut-targeted therapy, all scales and imaging were repeated. Paired sample <i>t</i>-tests were used to compare differences in z-score standardized amplitude of low-frequency fluctuation (zALFF) and z-score standardized regional homogeneity (zReHo) pre- and post-treatment. Correction was carried out using the Gaussian random field (GRF). Spearman correlation analysis was performed between functional indices<sup><sup>,</sup></sup>s changes of altered brain regions and scale scores<sup><sup>,</sup></sup>s changes. <b>Results</b>Compared with before treatment, the IBS-SSS (<i>P </i>&lt; 0.001), HAMA (<i>P </i>= 0.004), HAMD (<i>P </i>= 0.026) and PSQI (<i>P </i>= 0.007) scores of IBS-D patients decreased significantly after intestinal targeted therapy. Decreased zALFF values in the cuneus, precuneus and calcarine fissure and surrounding cortex (GRF correction, voxel-level <i>P </i>&lt; 0.005, cluster-level <i>P </i>&lt; 0.05). Significant reductions in zReHo values in the cuneus, precuneus, and superior occipital gyrus (GRF correction, voxel-level <i>P </i>&lt; 0.005, cluster-level <i>P </i>&lt; 0.05). A significant positive correlation between changes in precuneus zALFF and the scores of the pain anxiety in HAMA (<i>r </i>= 0.405,<i> P </i>= 0.027), and between precuneus zReHo changes and the depression scores in HAMD (<i>r </i>= 0.498, <i>P </i>= 0.005). <b>Conclusions</b>Gut-targeted therapy in IBS-D patients improved intestinal symptoms, anxiety, depression and sleep quality, accompanied by reduced activity in the precuneus and cuneus. The decreased functional activity in the precuneus may underlie the alleviation of anxiety and depressive symptoms. ]]></description>
<pubDate>Sun,20 Jul 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research on autism brain function network and gradient feature classification based on ensemble learning]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.07.002</link>
<description><![CDATA[<b>Objective</b>To explore the classification performance of resting-state brain functional networks and gradient features in patients with autism spectrum disorders (ASD) based on multimodal machine learning and ensemble learning classification models. <b>Materials and Methods</b>Based on 246 ASD patients and 251 healthy controls (HC), this study used two independent samples <i>t</i>-test to analyse the differences between the results of independent component analysis, gradient analysis, and static functional network connectivity (sFNC) and dynamic functional gradient (dFNG) features to construct a multimodal machine learning classification model. sFNC and dFNG features were used to construct a multimodal machine learning classification model. <b>Results</b>(1) The static connectivity strength of the default network (TN-DM), visual temporal lobe (VI-OT), and visual occipital lobe (VI-OC) networks in ASD patients was significantly weakened, while the connectivity strength between higher cognition frontal lobe (HC-FR) and significant network (TN-SA) was significantly enhanced (<i>P</i> &lt; 0.05, false discovery rate, FDR correction); (2) Dynamic gradient clustering analysis showed that ASD patients remained in the frontal lobe sensorimotor dominant state for a long time in low dimensional space (<i>P</i> &lt; 0.05); (3) The multimodal machine learning model results of sFNC and dFNG show that dFNG and sFNC have significant collaborative classification contributions, significantly improving classification accuracy (accuracy = 99.3%). <b>Conclusions</b>Patients with ASD have systemic abnormalities at both the sFNC and dFNG levels. A multimodal integrated learning model based on the features of sFNC and dFNG can efficiently classify ASD. ]]></description>
<pubDate>Sun,20 Jul 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Predictive efficiency of magnetic resonance vessel wall imaging on vertebrobasilar dolichoectasia with posterior circulation infarction]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.07.003</link>
<description><![CDATA[<b>Objective</b>To explore the predictive efficiency of 3.0 T high-resolution magnetic resonance vessel wall imaging (HRMR-VWI) on vertebrobasilar dolichoectasia (VBD) with posterior circulation infarction. <b>Materials and Methods</b>The clinical data of 200 patients with VBD in the hospital were retrospectively analyzed from May 2021 to June 2024. All patients received HRMR-VWI examination, and were followed up until March 2025. During follow-up, 4 cases were lost to follow-up for personal reasons, with the shedding rate of 2.00%. The patients were divided into study group (with posterior circulation infarction, 142 cases) and control group (without posterior circulation infarction, 54 cases) according to whether they were complicated with posterior circulation infarction. The predictive value of HRMR-VWI indicators on VBD with posterior circulation infarction was analyzed. According to the degree of vascular stenosis, the patients in study group were classified into mild stenosis (25% ≤ measured vascular stenosis rate < 50%), moderate stenosis (50% ≤ measured vascular stenosis rate < 70%) and severe stenosis (measured vascular stenosis rate ≥ 70%). The relationship between HRMR-VWI indicators and vascular stenosis degree in patients with posterior circulation infarction was analyzed. <b>Results</b>The lumen area at the narrowest level in study group was smaller than that in control group while the vascular wall area and plaque area were larger than those in control group, and the plaque load and remodeling index were higher, with statistical differences (<i>P </i>< 0.05). Receiver operating characteristic (ROC) curve showed that the area under the curve (AUC) of combined detection of HRMR-VWI indicators in predicting VBD with posterior circulation infarction was greater than that of single detection of each indicator, with a statistical significance (<i>P </i>< 0.05). The levels of triglyceride, total cholesterol, low density lipoprotein, apolipoprotein A1 and fibrinogen in study group were higher while and the level of high density lipoprotein was lower than that in control group, and the proportions of patients with lumen area < 3.08 mm<sup>2</sup>, vascular wall area ≥ 10.65 mm<sup>2</sup>, plaque area ≥ 3.14 mm<sup>2</sup>, plaque load ≥ 0.74 and remodeling index ≥ 1.01 were higher, with statistical differences (<i>P </i>< 0.05). The increases of total cholesterol, apolipoprotein A1 and fibrinogen, reduction of lumen area at the narrowest level, reduction of vascular wall area, enlargement of plaque area and increases of plaque load and remodeling index were the risk factors of VBD with posterior circulation infarction (<i>P </i>< 0.05). The proportions of BA and VA unstable plaques in study group were higher than those in control group, with statistical differences (<i>P </i>< 0.05). In VBD patients, the blood vessel area and lumen area at the narrowest level were negatively correlated with the degree of vascular stenosis while the plaque area, plaque load and remodeling index were positively correlated with the degree of vascular stenosis (<i>P </i>< 0.05). <b>Conclusions</b>3.0 T HRMR-VWI has predictive value on VBD patients with posterior circulation infarction, and the changes of HRMR-VWI indicators are related to posterior circulation infarction in patients. ]]></description>
<pubDate>Sun,20 Jul 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Value of MRI based on haemodynamic parameters and apparent diffusion coefficient in the differential diagnosis of breast phyllodes tumours and fibroadenomas]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.07.004</link>
<description><![CDATA[<b>Objective</b>To investigate the diagnostic value of magnetic resonance imaging (MRI), based on morphological features, hemodynamic characteristics and apparent diffusion coefficient (ADC), in differentiating phyllodes tumors (PT) from fibroadenomas (FA) of the breast. <b>Materials and Methods</b>MRI data of 26 pathologically confirmed PT cases (26 lesions) and 53 FA cases (59 lesions) were retrospectively analyzed. The morphological features, dynamic contrast-enhanced MRI (DCE-MRI) parameters, mean ADC, and relative apparent diffusion coefficient (rADC) between the two groups were measured and calculated. The <i>χ</i><sup>2</sup> test and independent sample <i>t</i> test were used to assess intergroup differences. Logistic regression was used to establish a combined model. The non-parametric receiver operating characteristic (ROC) curves were generated for mean ADC value and rADC values. The DeLong test was employed to compare the differences in diagnostic efficacy between mean ADC value, rADC values and the combined model. Calibration curve was drawn to evaluate the model<sup><sup>,</sup></sup>s consistency, and finally assessed the model<sup><sup>,</sup></sup>s clinical application value through decision curve analysis (DCA). <b>Results</b>The mean age of patients in the PT group (39.92 ± 8.96 years) was significantly higher than that in the FA group (33.37 ± 10.22 years) (<i>P</i> &lt; 0.05). PT lesions exhibited more lobulated shape, irregular or spiculated margins, low-signal segregation in T2-weighted imaging (T2WI), and cystic degeneration or necrosis. DCE-MRI showed fast enhancement in the initial phase and heterogeneous enhancement, with time-intensity curves (TIC) type II compared to FAs. The mean ADC, rADC1, and rADC2 values of the PTs were (1.500 ± 0.153) ×10⁻³ mm²/s, 0.870 ± 0.070 and 0.760 ± 0.070, these values were significantly lower than those of the FAs (<i>P </i>&lt; 0.05). These values were statistically significant (<i>P</i> &lt; 0.05). The diagnostic threshold of mean ADC value was 1.525×10⁻³ mm²/s, the area under the curve (AUC) was 0.730, the sensitivity was 65.4%, and the specificity was 83.1%. The sensitivity of the rADC value was higher than the mean ADC value, but its specificity was lower. The diagnostic threshold of rADC1 value was 0.923 corresponding to AUC was 0.791, the diagnostic threshold of rADC2 value was 0.847, the corresponding AUC was reduced to 0.647, and the diagnostic threshold of the combined model (lesion margin, T2WI low signal separation feature, rADC1 value) was 0.636 corresponding to AUC was 0.904, with sensitivity of 91.5% and specificity of 80.8%. The DeLong test was used to compare the AUC differences between rADC1 value, rADC2 and the combined model, and the diagnostic performance of the combined model was better than rADC1 value (<i>P </i>= 0.007) and rADC2 value (<i>P </i>&lt; 0.001). The calibration curve demonstrated excellent agreement between the predicted probability of the combined model and actual outcome. DCA further confirmed the superior clinical utility of the combined model, providing a higher net benefit than single-parameter models across threshold probabilities of 0.2 to 0.9. <b>Conclusions</b>The multiparametric MRI model based on hemodynamic features (tumor margins, T2WI hypointense septations) and rADC1 values can effectively predict PT preoperatively, demonstrating favorable discriminative ability, calibration accuracy, and clinical utility. This approach facilitates clinical diagnosis, treatment planning, and prognosis improvement for PT. ]]></description>
<pubDate>Sun,20 Jul 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Evaluation of liver function and prediction of first decompensation event in patients with chronic hepatitis B by MRI functional liver imaging score and spontaneous portosystemic shunt]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.07.005</link>
<description><![CDATA[<b>Objective</b>To investigate the value of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) enhanced MRI functional liver imaging score (FLIS) and spontaneous portal shunt (SPSS) on the liver function assessment in patients with chronic hepatitis B (CHB) and to construct a prediction model for the first decompensation event in CHB patients. <b>Materials and methods</b>A retrospective analysis was conducted on clinical and MRI data from 268 CHB patients who underwent Gd-EOB-DTPA-enhanced MRI at the Second Hospital of Lanzhou University between October 2019 and October 2021. The cohort included 192 males and 76 females, aged 21 to 77 years (mean ± SD: 48.5 ± 9.4). All patients had complete clinical laboratory test results within one week before or after the MRI examination. Patients were stratified into four groups based on the Fibrosis-4 (FIB-4) index and Child-Pugh (CP) classification: prehepatic cirrhosis chronic liver disease (CLD), early cirrhosis Child-Pugh A (CP A), mid-stage cirrhosis Child-Pugh B (CP B), and late cirrhosis Child-Pugh C (CP C). Comparison of clinical laboratory indicators and imaging parameters [FLIS, SPSS, spleen craniocaudal diameter (SCCD), portal vein width, splenic vein width] across groups using Friedman tests, chi-square tests and ANOVA for correlation analysis. Interobserver consistency of FLIS and its three components assessed via Kappa analysis. Diagnostic performance of imaging parameters for group differentiation evaluated using receiver operating characteristic (ROC) curves. Cox regression analysis of laboratory and imaging parameters with intergroup differences to predict the first decompensation event in CHB patients. <b>Results</b>(1) FLIS and its three parameters were moderately to strongly correlated with clinical groups (<i>r </i>= -0.464 to -0.671, <i>P </i>&lt; 0.001). (2) Interobserver agreement for FLIS and its components was excellent (consistency coefficients: 0.931 to 1.000, <i>P </i>&lt; 0.001). (3) SCCD was the optimal parameter for distinguishing CLD from CP A (AUC: 0.873, 95% <i>CI</i>: 0.769 to 0.904). The FLIS cutoff value of ≥ 5 best differentiated CLD/CP A from CP B/CP C (AUC: 0.839, 95% <i>CI</i>: 0.790 to 0.889), while FLIS ≥ 4 optimally separated CP B from CP C (AUC: 0.872, 95% <i>CI</i>: 0.820 to 0.924). (4) FLIS was not an independent predictor of first decompensation in CHB patients (log-rank of survival analysis, <i>P </i>= 0.203). Univariate analysis identified SPSS [hazard ratio (HR): 4.49] and SCCD ≥ 13.4 cm (HR: 4.81) as significant predictors (<i>P</i> &lt; 0.05). The combination of SPSS (dichotomized) and SCCD provided superior predictive value for decompensation (AUC: 0.708, 95% <i>CI</i>: 0.631 to 0.785). <b>Conclusions</b>FLIS demonstrates optimal diagnostic performance for liver function grading in CHB patients. For predicting the first decompensation event in CHB patients, SPSS and SCCD exhibit significant predictive value. ]]></description>
<pubDate>Sun,20 Jul 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[The value of a clinical-multiparametric MRI prediction model based on O-RADS MRI scoring system in differentiating between benign and malignant adnexal masses of the uterus]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.07.006</link>
<description><![CDATA[<b>Objective</b>To develop and validate a clinical-multiparametric MRI predictive model incorporating the ovarian-adnexal reporting and data system (O-RADS) MRI score, and to evaluate its utility in distinguishing benign from malignant adnexal lesions. <b>Materials and Methods</b>A retrospective study was performed to analyze 165 cases of adnexal masses that underwent pelvic MRI plain scan + enhanced examination and were confirmed by pathological histology from 2020 to 2023. The preoperative clinical indicators and imaging characteristics of the patients were collected. The differences in various indicators between benign and malignant mass groups were compared by univariate analysis. Multivariate logistic regression was used to screen out independent risk factors for predicting adnexal malignant masses, and a logistic regression prediction model was constructed and displayed in a nomogram. Receiver operating characteristic (ROC) curve, DeLong test, integrated discrimination improvement index (IDI) and net reclassification index (NRI) were used to evaluate and compare the difference in differential diagnostic performance between the logistic regression model based on O-RADS MRI score and the simple O-RADS MRI score. Calibration curves were drawn to evaluate the calibration ability of the logistic regression model. Decision curve analysis (DCA) was used to evaluate the clinical net benefits of the two models. <b>Results</b>After screening, a total of 165 patients (with 170 masses) were collected. The age ranged from 11 to 87 years old. The median age of the benign group was 49.50 (28.75, 60.75) years old, and the median age of the malignant group was 50.50 (38.75, 62.00) years old. The results of univariate analysis showed that there were significant differences in carbohydrate antigen 125 (CA125), human epididymis protein 4 (HE4), platelet count (PLT), lesion boundary clarity, O-RADS MRI scores, mean apparent diffusion coefficient (ADC<sub>mean</sub>) of solid components, and ADC values of cystic fluid between benign and malignant masses (all <i>P</i> &lt; 0.05) . Multifactorial logistic regression analysis showed that increased HE4 level (OR = 1.011, <i>P</i> = 0.028), increased O-RADS MRI score (OR<i> </i>= 3.085, <i>P</i> = 0.001), and decreased ADC<sub>mean</sub> value (OR = 0.005, <i>P</i> &lt; 0.001) were independent predictors of malignant lesions of adnexal masses. The logistic regression model was established by combining O-RADS MRI score, ADC<sub>mean</sub>, and HE4. The area under the curve (AUC) for distinguishing benign and malignant adnexal masses was 0.944, the sensitivity was 84.9%, and the specificity was 90.5%, which were better than the simple O-RADS MRI score (AUC was 0.849, sensitivity was 89.5%, and specificity was 81.0%). DeLong test showed that the difference in AUC between the two models was statistically significant (<i>P</i> &lt; 0.001). NRI and IDI showed that the logistic regression model had better differential diagnostic performance for adnexal masses than the O-RADS MRI score, and the difference were statistically significant (<i>P </i>&lt; 0.05). The calibration curves showed that the calibration of the logistic regression model was good; DCA showed that the clinical net yield of the logistic regression model was greater than that of the O-RADS MRI score. <b>Conclusions</b>The logistic regression model constructed by combining O-RADS MRI score, ADC<sub>mean</sub> and HE4 has high efficacy in the differential diagnosis of benign and malignant adnexal masses, and its differentiation efficiency is better than that of the simple O-RADS MRI score, and can be used to effectively distinguish benign and malignant adnexal masses before surgery. ]]></description>
<pubDate>Sun,20 Jul 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Clinical utility of cinematic volume rendering technique in lumbosacral plexus nerve sheath tumors: A comparative study with maximum intensity projection]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.07.007</link>
<description><![CDATA[<b>Objective</b>To comparatively analyze the visualization differences between cinematic volume rendering technique (CVRT) and maximum intensity projection (MIP) in imaging lumbosacral plexus nerve sheath tumors, and further explore the clinical potential of CVRT in preoperative tumor assessment, treatment planning, and intraoperative injury reduction. <b>Materials and Methods</b>Retrospective analysis of 33 patients with lumbosacral plexus nerve sheath tumors, and all of them underwent three-dimensional fast spin echo short-time flip recovery sequence imaging (3D-STIR-SPACE) after enhancement. 3D-STIR-SPACE images were used as the original images, and were processed by maximum density projection MIP and CVRT, respectively. Overall image quality (OIQ), lumbosacral plexus (LSP) versus tumor display sharpness, LSP versus tumor spatial location resolution, and image diagnostic confidence level (DCL) of MIP and CVRT images were evaluated using a 4-point scale by two investigators. The performance scores of MIP and CVRT images were statistically analyzed using the non-parametric Wilcoxon signed rank test. The intra-class correlation coefficient (ICC) was used to assess the agreement between the two methods, CVRT and MIP, respectively, and the surgical results in determining the size and location of the tumor and its relationship with the LSP. <b>Results</b>Compared with MIP images, CVRT images obtained superior image quality, LSP with tumor display clarity and spatial location resolution, and very high diagnostic confidence, and both were significantly different (<i>P </i>&lt; 0.05). In the consistency analysis, CVRT images exhibited ICC values that were comparable to those of MIP images (CVRT: ICC = 0.929 to 0.957; MIP: ICC = 0.878 to 0.922). The consistency between the results derived from CVRT image analysis and the surgical outcomes was at least equivalent to or better than that obtained from MIP image analysis (CVRT vs. MIP, ICC values: 0.988 vs. 0.969, 1.000 vs. 1.000, 0.943 vs. 0.807). <b>Conclusions</b>Compared with MIP, CVRT provides a clearer depiction of the anatomical relationship between the tumor and the lumbosacral plexus nerve, providing more imaging information for clinical diagnosis and treatment. ]]></description>
<pubDate>Sun,20 Jul 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[The value of deep learning reconstruction combined with small field-of-view high-resolution scanning in improving the quality of finger magnetic resonance images]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.07.008</link>
<description><![CDATA[<b>Objective</b>To explore the value of small field-of-view (sFOV) high-resolution scanning based on deep-learning reconstruction (DLR) algorithm in improving the imaging quality of finger magnetic resonance imaging (MRI). <b>Materials and Methods</b>Thirty-three healthy volunteers and 24 patients with hand diseases were prospectively recruited. Both the small field-of-view high-resolution T2-weighted spin-echo sequence (TSE-sFOV) and DLR combined with TSE-sFOV (TSE<sub>DL</sub>-sFOV), were conducted on the subjects. A 4-point scale was used to subjectively evaluate the overall image quality (based on image contrast, edge sharpness, noise and artifact) and the clarity of anatomical structures (including bone, articular cartilage, tendon and ligament) in the two sets of images from 57 samples; Additionally, The lesion display (including lesion contrast and edge sharpness, lesion location and internal morphology) and diagnostic confidence were scored for 24 samples. The disease detection capabilities (including bone changes, joint space changes, tendon abnormalities, and soft tissue abnormalities) of the two groups of images from 57 samples were assessed as either 0 or 1. The signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) of the two sets of images were compared. <b>Results</b>In the subjective evaluation, the TSE<sub>DL</sub>-sFOV group of images scored higher than the TSE-sFOV in overall image quality, bone and articular cartilage (<i>P </i>&lt; 0.05), while there was no statistical difference in tendon and ligament scores. For lesion display and diagnostic confidence in the 24 samples, the TSE<sub>DL</sub>-sFOV group of images scored higher than the TSE-sFOV group, with statistical difference (<i>P </i>&lt; 0.05). In terms of disease detection capabilities, there was no statistical difference between the two groups of images (<i>P </i>&gt; 0.05), and the consistency between the two sets of images was excellent (Kappa &gt; 0.84). In the objective evaluation, the SNR and CNR of the TSE<sub>DL</sub>-sFOV group of images were higher than those of the TSE-sFOV group (<i>P </i>&lt; 0.05). <b>Conclusions</b>DLR combined with sFOV finger MRI can reduce the noise and improve the image quality under the premise of shortening scanning time. This provides more precise images for clinic. ]]></description>
<pubDate>Sun,20 Jul 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[The feasibility study of quantitative assessment of lumbar paravertebral muscles by synthetic magnetic resonance technique]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.07.009</link>
<description><![CDATA[<b>Objective</b>To explore the feasibility of magnetic resonance image complication (MAGIC) technique in quantitative evaluation of lumbar paraspinal muscles. <b>Materials and Methods</b>A total of 32 patients with lumbar spine MR examination were prospectively included, acquisition of axial MAGIC, T2/T1 mapping and T2/T1WI images. The image quality (artifact, resolution, contrast, liquid signal) was scored by Likert scale, and the signal-to-noise ratio (SNR) of vertebral body, multifidus muscle and erector spinae muscle was measured. The difference and consistency of T1/T2 values between MAGIC and traditional quantitative techniques were compared. <b>Results</b>The average time for collecting conventional T2 and T1 comparative sequences and conventional T2 and T1 quantitative sequences was 1028 s, while the average time for collecting MAGIC sequences was 702 s, a time reduction of nearly 31.7%. The image artifacts of MAGIC T2 were less than those of conventional T2WI (<i>P </i>&lt; 0.001), liquid signal intensity was higher (<i>P </i>= 0.027), but the spatial resolution was lower (<i>P</i> &lt; 0.001). There was no significant difference in contrast between the two groups (<i>P &gt; </i>0.05). The SNR of MAGIC T1 images was lower than that of conventional images in vertebral body (<i>P </i>= 0.003), multifidus (<i>P </i>= 0.007) and erector spinae (<i>P &lt; </i>0.001). The SNR of MAGIC T2 images in the vertebral region was lower than that of conventional images (<i>P &lt; </i>0.001), and the SNR in the multifidus (<i>P &lt; </i>0.001) and erector spinae (<i>P </i>= 0.024) regions was higher than that of conventional images. The axial MAGIC T2MAP was highly correlated with the T2 value measured by T2 mapping: T2 value of multifidus muscle (<i>r </i>= 0.768, <i>P &lt; </i>0.001) and T2 value of erector spinae muscle (<i>r </i>= 0.836, <i>P &lt; </i>0.001). However, there was no significant correlation between MAGIC T1MAP and T1 values measured by T1 mapping (|<i>r</i>| <i>&lt; </i>0.3, <i>P &gt; </i>0.05). The repeatability of the two measurements was high [intra-class correlation coefficient (ICC)<sub>T2</sub> = 0.904, ICC<sub>T1</sub> = 0.960]. <b>Conclusions</b>MAGIC technology can shorten the scanning time by 31.7%, provide images that meet clinical needs, and is stably applied to T2 relaxation quantification of lumbar paraspinal muscles. ]]></description>
<pubDate>Sun,20 Jul 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Application value of diffusion-weighted imaging based on deep learning reconstruction algorithm in cranial MRI examination]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.07.010</link>
<description><![CDATA[<b>Objective</b>To explore the application value of diffusion weighted imaging (DWI) based on deep learning reconstruction algorithm (DLR) in cranial MRI examination. <b>Materials and Methods</b>A retrospective analysis was conducted on the MRI imaging data of 40 patients with intracranial space occupying lesions. Four sets of image quality differences were compared between conventional reconstruction (c2-DWI, c1-DWI) and DLR (DL2-DWI, DL1-DWI) with a number of excitations (NEX) of 2 and 1. The signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) of gray and white matter were compared, as well as the apparent diffusion coefficient (ADC) of the lesion area and the contralateral normal area. Two physicians used a double-blind method to score the overall image quality, noise level, and magnetic susceptibility artifacts using a 5-point scale. <b>Results</b>The SNR and CNR of DLR sequence gray matter and white matter were higher than those of conventional reconstructed sequence, and the difference was statistically significant (<i>P </i>&lt; 0.001). There was no statistically significant difference in ADC values between the lesion area and the contralateral normal area (<i>P </i>&gt; 0.05). The overall image quality and noise level scores of DLR are higher than those of conventional reconstruction, and the difference is statistically significant (<i>P </i>&lt; 0.001). There was no statistically significant difference in magnetic sensitivity artifacts (<i>P </i>&gt; 0.05). <b>Conclusions</b>DLR can significantly improve the SNR, CNR, and subjective score of DWI images, effectively reducing image noise. While NEX is halved and scanning time is shortened, although there is limited improvement in magnetic sensitivity artifacts, it does not affect the accuracy of ADC values. ]]></description>
<pubDate>Sun,20 Jul 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Clinical evaluation of a transportable MRI detection array for multi-site human imaging applications]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.07.011</link>
<description><![CDATA[<b>Objective</b>To evaluate the feasibility and imaging performance of a self-developed transportable magnetic resonance imaging detection array (TMRDA) for multi-site imaging of human body. <b>Materials and Methods</b>Phantom studies were performed to compare the magnetic resonance imaging (MRI) performance of 24-channel TMRDA against two commercial coils: a 24-channel head and neck combined coil and a 24-channel abdominal coil. Subsequently, 34 healthy volunteers underwent standardized scans (brain, liver, and hip) using both systems. Quantitative metrics including signal-to-noise ratio (SNR), uniformity, percent signal ghosting, contrast-to-noise ratio (CNR), contrast ratio (CR), and MRI quantitative parameters were evaluated. Two radiologists performed subjective image quality assessments. <b>Results</b>In phantom studies, TMRDA demonstrated significantly superior SNR and uniformity on both T1-weighted imaging and T2-weighted imaging compared to commercial coils (<i>P </i>&lt; 0.001), with comparable or better percent signal ghosting. Volunteer studies showed TMRDA achieved significantly higher SNR and CNR across all anatomical regions (<i>P </i>&lt; 0.001) with equivalent or better CR. No significant differences were observed in quantitative MRI parameters or subjective image quality scores (<i>P </i>&gt; 0.05). <b>Conclusions</b>The TMRDA achieves comparable or superior image quality to dedicated commercial coils for brain, liver, and hip MRI examinations, demonstrating significant clinical utility for multi-site applications while maintaining diagnostic confidence. ]]></description>
<pubDate>Sun,20 Jul 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress in neuroimaging of autism spectrum disorder]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.07.015</link>
<description><![CDATA[Autism spectrum disorder (ASD) is characterized by core symptoms of social communication deficits and restricted, repetitive behaviors, with its global prevalence steadily increasing. However, the brain mechanism of ASD is still unclear, and its early diagnosis and early intervention are limited. Neuroimaging is an important research tool for exploring the brain mechanisms of ASD, but few reviews have summarized this research progress. This review primarily summarizes the neuroimaging alterations in ASD, their clinical significance and associated brain mechanisms, in order to support subsequent imaging studies and advance the exploration of brain mechanisms. ]]></description>
<pubDate>Sun,20 Jul 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress of dynamic functional connectivity in adolescent depression]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.07.016</link>
<description><![CDATA[Depression is a severe mental disorder that poses a significant threat to the physical and mental health of adolescents. Its underlying neuropathological mechanisms, particularly the core neural circuits associated with abnormalities in dynamic functional networks, remain incompletely elucidated. Dynamic functional connectivity (dFC) can capture the dynamic characteristics of brain functional networks over time, which is crucial for a deeper understanding of the occurrence and development mechanisms of adolescent depression. However, the application of dFC analysis methods in adolescent depression has not yet been systematically reviewed and summarized. This article reviews the important results, limitations, and development prospects of dFC analysis methods such as sliding window correlation (SWC), co-activation patterns (CAPs), dynamic independent component analysis (dyn-ICA), and dynamic causal modeling (DCM) in adolescent depression research from the perspectives of technical principles and clinical applications. It provides a new perspective for further understanding the neuropathological mechanisms of adolescent depression, exploring new imaging markers, and potential clinical treatment plans. This article suggests that analyzing the dynamic features of adolescent brain networks can provide new ideas for developing precise diagnosis and treatment strategies for adolescent depression. ]]></description>
<pubDate>Sun,20 Jul 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[The mechanisms of rTMS treatment for major depressive disorder through structural-functional MRI]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.07.017</link>
<description><![CDATA[Major depressive disorder (MDD) is a prevalent psychiatric condition associated with alterations in brain structural and functional connectivity, which significantly affects physical, psychological, and social functioning. Repetitive transcranial magnetic stimulation (rTMS), a non-invasive neuromodulation technique that applies magnetic pulses to the cortical regions, has shown significant efficacy in the treatment of MDD. However, the specific mechanisms by which it exerts its antidepressant effects through regulating brain structure and function remain unclear. Although multimodal MRI has provided valuable tools for revealing the neuroregulatory mechanisms of rTMS, existing reviews mostly focus on separate analyses of structural or functional changes, without systematically integrating how rTMS affects the structural-functional coupling of the brain. Therefore, we systematically summarize the research progress on rTMS-induced changes in the brain<sup><sup>,</sup></sup>s structure-function coupling during MDD treatment, based on structural-functional MRI. It aims to provide new perspectives for optimizing the selection of stimulation targets and offers methodological suggestions for the multi-scale objective evaluation of rTMS intervention effects. We propose that a deeper understanding of the regulatory mechanisms of rTMS on brain structure-function coupling is a core to achieving precision in MDD treatment and objectivity in efficacy evaluation. ]]></description>
<pubDate>Sun,20 Jul 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[MRI-based research advances in the glymphatic system in Alzheimer<sup><sup>,</sup></sup>s disease]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.07.018</link>
<description><![CDATA[With the acceleration of global aging, research on the pathogenesis of Alzheimer<sup><sup>,</sup></sup>s disease (AD) has become a central issue in neuroscience. The glymphatic system (GS), a perivascular network responsible for the clearance of metabolic waste in the central nervous system, plays a key role in the accumulation of amyloid-beta (Aβ) and Tau pathology associated with AD. Early visualization of structural and functional changes in GS is important to diagnose some of the neurodegenerative diseases and develop new therapeutic options. In recent years, multimodal magnetic resonance imaging (MRI) techniques—including dynamic contrast-enhanced MRI (DCE-MRI), diffusion tensor imaging analysis along the perivascular space (DTI-ALPS), chemical-exchange-saturation-transfer MRI (CEST-MRI), and resting state functional MRI (rs-fMRI)—have gradually visualized the structure and function of GS in a noninvasive or minimally invasive way. In this paper, we review the preclinical and clinical research evidence and dynamically monitor the GS functional changes and influx-efflux pathways using multimodal MRI technology. By elucidating visualized evidence of GS dysfunction and identifying associated neuroimaging biomarkers, this work aims to provide novel insights into early AD diagnosis and the underlying pathological mechanisms. ]]></description>
<pubDate>Sun,20 Jul 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress of multimodal MRI technology on the changes in brain function of patients with amblyopia]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.07.019</link>
<description><![CDATA[The impairment of visual function in patients with amblyopia is closely related to the changes in brain function. MRI technology enables precise imaging of the brain<sup><sup>,</sup></sup>s structure and function under non-invasive conditions, allowing for an in-depth analysis of the characteristics and mechanisms of the changes in brain function in amblyopia. This article summarizes the literature on the use of MRI technology in recent years to study the brain function mechanisms in patients with amblyopia. Structural MRI shows that the gray matter volume and cortical thickness in brain regions related to the visual pathway of amblyopic patients is reduced. Functional MRI, through task-based fMRI, reveals reduced activation of the visual cortex, and resting-state fMRI shows abnormalities in the amplitude of low-frequency fluctuations (ALFF) and regional homogeneity (ReHo) values of neurons in local brain regions, changes in the functional connectivity of the primary and secondary visual pathways, as well as alterations in brain functional networks such as the default mode network and the salience network. Diffusion MRI reveals a decrease in the fractional anisotropy (FA) value and an increase in the mean diffusivity (MD) value of white matter fiber tracts. Magnetic resonance spectroscopy (MRS) shows a decrease in the γ-aminobutyric acid (GABA) level in the visual cortex. Based on the arterial spin labeling (ASL) cerebral perfusion imaging technique, it has been found that cerebral blood perfusion in certain brain regions of amblyopic patients is reduced. This article reviews the contents mentioned above, aiming to provide more references for the study of the brain mechanisms of amblyopia. ]]></description>
<pubDate>Sun,20 Jul 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress of MRI on the development of cerebral cortex related to fine motor skills in preterm infants]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.07.020</link>
<description><![CDATA[In recent years, the survival rate of preterm infants has increased, but the risk of neurodevelopmental disorders has also risen, with motor development problems being particularly prominent. As a key indicator of neurobehavioral development, fine motor skills directly affect early quality of life and long-term cognitive and socio-emotional development. MRI, with its advantages of non-invasiveness, high soft tissue resolution, and functional imaging, has become a core technology for evaluating brain development in preterm infants. However, current research on the association between fine motor development in preterm infants and brain MRI characteristics has limitations, and systematic frameworks for studying pathological mechanisms, technological transformation, and intervention pathways have not yet been established. Studies over the past five years have shown significant differences in MRI indices such as cerebral cortical thickness and gray matter volume between preterm and term infants. These structural abnormalities serve as the biological basis for delayed fine motor development and influence the long-term development of cognitive and motor coordination through neural circuit remodeling. New technologies such as multimodal functional MRI provide new perspectives for dynamically tracking brain development and predicting neurodevelopmental outcomes. Current research faces challenges such as small sample cross-sectional designs, lack of longitudinal data, and insufficient multimodal imaging-clinical phenotype association models. In the future, large-sample longitudinal studies, multimodal MRI technologies, and interdisciplinary approaches are needed to provide a basis for accurate assessment of fine motor development and optimization of intervention strategies in preterm infants. This review focuses on the research progress of the correlation between fine motor development in premature infants and brain MRI detection, aiming to provide new references for clinical evaluation and intervention strategies. ]]></description>
<pubDate>Sun,20 Jul 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress of multimodal MRI in mild traumatic brain injury]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.07.021</link>
<description><![CDATA[Mild traumatic brain injury (mTBI) accounts for over 80% of all traumatic brain injury (TBI) cases and is one of the common neurological disorders. However, the current understanding of the diagnosis of mTBI and the underlying neurophysiological mechanisms of post-traumatic cognitive changes remains incomplete. This lack of clarity hinders the early diagnosis, treatment decision-making, and prognosis evaluation for mTBI. In recent years, an increasing number of multimodal magnetic resonance imaging (MRI) techniques have been applied to the diagnosis of mTBI. These include functional magnetic resonance imaging (fMRI), arterial spin labeling (ASL) perfusion imaging, susceptibility-weighted imaging (SWI), and diffusion tensor imaging (DTI). These techniques have enhanced our understanding of the neuropathological mechanisms of mTBI from different perspectives. This article reviews the application progress of the above-mentioned multimodal MRI techniques in mTBI and evaluates their advantages and disadvantages, providing new ideas for future research. ]]></description>
<pubDate>Sun,20 Jul 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Advances in multimodal MRI studies of brain alterations induced by acute mountain sickness]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.07.022</link>
<description><![CDATA[Acute mountain sickness (AMS) is the most common form of altitude illness. With the booming tourism industry, frequent military operations, and increasing popularity of outdoor adventures, the number of individuals entering high-altitude regions has risen steadily, making early AMS diagnosis critical to preventing progression to severe, life-threatening stages. Recent advances in neuroimaging have opened new avenues for clinical diagnosis and in-depth analysis of AMS pathophysiology. This article reviews the latest applications of multimodal MRI in assessing brain volume, microstructural damage, and cerebral blood flow perfusion, offering novel perspectives for AMS diagnosis and mechanistic exploration. ]]></description>
<pubDate>Sun,20 Jul 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research advances in multimodal magnetic resonance imaging for brain structural and functional alterations in chronic mountain sickness]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.07.023</link>
<description><![CDATA[With the continuous advancement of high-altitude medicine research, chronic mountain sickness (CMS), as a special pathological condition caused by prolonged hypoxia exposure, has become a critical public health issue in high-altitude medicine that urgently requires resolution. Currently, the pathophysiological mechanisms underlying CMS-induced morphological changes and functional abnormalities in brain tissue remain incompletely understood, and systematic conclusions regarding its imaging characteristics are still lacking. In this context, the use of non-invasive imaging techniques for early diagnosis and intervention of CMS holds significant clinical value.In recent years, particularly magnetic resonance imaging (MRI) and its derivative techniques, has demonstrated remarkable advantages in both the mechanistic research and clinical diagnosis of CMS. This article systematically reviews the research progress on CMS-related structural and functional brain alterations based on multimodal MRI technologies, with a focus on the application value of structural MRI and functional MRI in elucidating the neuropathological mechanisms of CMS. The aim is to provide objective imaging evidence for the early diagnosis and precision treatment of CMS. ]]></description>
<pubDate>Sun,20 Jul 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Application of multimodal imaging techniques in white matter hyperintensity and coronary atherosclerosis]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.07.024</link>
<description><![CDATA[White matter hyperintensities (WMH), a characteristic imaging manifestation of cerebral small vessel disease, are associated with cognitive impairment and dementia risk. Coronary atherosclerosis (CAS), as a crucial pathological feature of cardiovascular diseases, exerts systemic impacts on the overall health of the cardio-cerebrovascular system. In recent years, advanced imaging technologies such as high-resolution magnetic resonance imaging (MRI) and coronary computed tomography angiography (CCTA) have provided novel perspectives for in-depth exploration of the pathological mechanisms and interrelationships between CAS and WMH. This article focuses on elucidating the applications of multimodal imaging techniques in both conditions and synthesizing evidence regarding the correlations in imaging characteristics between CAS and WMH, aiming to provide imaging-based references for early clinical identification of high-risk populations and formulation of intervention strategies. ]]></description>
<pubDate>Sun,20 Jul 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Advances in the application of magnetic resonance habitat imaging for the diagnosis and treatment of breast cancer]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.07.025</link>
<description><![CDATA[Breast cancer is one of the most common malignancies worldwide, and early diagnosis combined with standardized treatment are critical for improving patient prognosis. Tumor heterogeneity, as a key challenge in breast cancer research and clinical management, profoundly impacts tumor progression, metastatic potential, and treatment response. Tumor habitat imaging, which performs cluster analysis on intra-tumoral regions and their microenvironment by identifying subregions with similar characteristics, provides new perspectives into intratumoral heterogeneity. Habitat imaging based on multiparametric magnetic resonance imaging (MRI), by virtue of its technical advantages such as non-invasiveness and high resolution, enables non-invasive quantification of tumor heterogeneity. This article reviews the research progress of habitat imaging in breast cancer MRI, covering its applications in predicting hormone receptor status, molecular subtypes, lymphovascular invasion, axillary lymph node metastasis, treatment response prediction and evaluation, and prognosis assessment. The aim is to provide new ideas for precision diagnosis and treatment of breast cancer (including early diagnosis, therapeutic efficacy assessment, etc.). ]]></description>
<pubDate>Sun,20 Jul 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Application progress of conventional and diffusion magnetic resonance imaging in non-puerperal mastitis]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.07.026</link>
<description><![CDATA[Non-puerperal mastitis (NPM) is an inflammatory disease occurring in female non-lactation period, has an unknown etiology and is prone to recurrence. Conventional antibiotics has limited efficacy, repeated rupture can lead to complications such as sinus tracts, and some cases are difficult to distinguish from malignant breast diseases. MRI can be of great help to the diagnosis of NPM and the differentiation from malignant breast diseases, and provide a reference for clinical determination of surgical procedures. At present, there are no relevant literature reviews on the application of conventional and diffusion MRI in differentiating various types of NPM and distinguishing NPM from malignant tumors. This article reviews the current status and research progress of conventional and diffusion magnetic resonance imaging in the diagnosis, classification and differentiation from breast cancer of NPM as well as the application of the artificial intelligence technologies such as combined radiomics, to improve reference for the clinical diagnosis of NPM. ]]></description>
<pubDate>Sun,20 Jul 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Advances in radiomics for predicting the efficacy of local treatments in liver malignancies]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.07.027</link>
<description><![CDATA[In recent years, the incidence of malignant liver tumors, including primary liver cancer and metastatic liver cancer, has been steadily increasing. Among comprehensive treatment strategies, in addition to systemic therapies, local treatments play a critical role. However, the presence of tumor heterogeneity leads to significant interpatient variability in response to local therapies. Radiomics, which extracts imperceptible intratumoral heterogeneity features from medical imaging, has greatly enhanced the ability to predict the efficacy of local treatments for malignant liver tumors. Previous studies have evaluated the predictive value of radiomics in both systemic and local treatment responses for hepatocellular carcinoma and colorectal liver metastases. Nevertheless, there is a lack of systematic reviews that comprehensively summarize the progress of radiomics applications in assessing the efficacy of local treatments for both primary and secondary malignant liver tumors. This review systematically outlines the current state of research on radiomics in various local treatment modalities for malignant liver tumors, including surgery, interventional therapy, ablation, and radiotherapy. It focuses on the application of radiomics in identifying treatment-sensitive populations, assessing recurrence risk, and predicting survival outcomes. In addition, this review addresses key obstacles in the clinical use of radiomics for local therapies of hepatic malignancies, and integrates current research focuses. It further outlines a practical, evidence-based model for precision treatment of liver cancers and highlights directions for future study. ]]></description>
<pubDate>Sun,20 Jul 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress of indicators related to the tumor immune microenvironment of intrahepatic cholangiocarcinoma based on radiomics]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.07.028</link>
<description><![CDATA[Intrahepatic cholangiocarcinoma (ICC) accounts for 10% to 20% of primary liver cancers, with its incidence increasing annually. Dynamic changes in key immune indicators within the tumor immune microenvironment (TIME) significantly impact ICC prognosis. Due to the limitations and lag of existing detection methods, radiomics technology enables non-invasive prediction and timely monitoring of TIME immune indicators, enhancing precise ICC diagnosis and treatment by analyzing intratumoral and peritumoral information. Radiomics uses machine learning to high-throughput extract imaging features, integrating clinical, pathological, genetic, and immunological parameters to construct predictive models for immune indicators. These models support ICC risk stratification, prognosis assessment, and development of novel immunotherapies. Current limitations include single predictive indicators and suboptimal model generalization. Future directions involve deep integration with radiogenomics, spatial transcriptomics, and other omics, developing multimodal fusion models, and establishing multi-center standardized databases to advance clinical translation. This review summarizes the quantification of TIME-related immune indicators based on radiomics and explores the correlations between these indicators. Provide a new perspective for the clinical diagnosis and treatment of ICC. ]]></description>
<pubDate>Sun,20 Jul 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress of radiomics in the diagnosis and treatment of gastric cancer]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.07.029</link>
<description><![CDATA[Gastric cancer is a high-incidence gastrointestinal malignancy in the world, and early diagnosis is difficult and the prognosis is poor. The accuracy of traditional imaging diagnosis is low, while pathological diagnosis has spatial heterogeneity and invasive limitations. Radiomics provides a non-invasive and reproducible new method for visualizing tumor heterogeneity and analyzing biological behaviors through high-throughput extraction and quantitative analysis of image features. Current research focuses on the application of radiomics in gastric cancer pathological classification (e.g., Lauren classification), molecular marker prediction, TNM staging and efficacy evaluation, and its models have shown high sensitivity and specificity in clinical validation, but still face challenges such as insufficient standardization, small sample size and lack of external validation. This article systematically reviews the research progress of radiomics in the diagnosis and treatment of gastric cancer, aiming to provide new ideas for individualized precision treatment and promote clinical translation. ]]></description>
<pubDate>Sun,20 Jul 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Advances in clinical and MRI research on lymph node metastasis in rectal cancer]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.07.030</link>
<description><![CDATA[Rectal cancer is one of the most common malignant tumors in China, with both its incidence and mortality rates demonstrating a consistent upward trend in recent years. Lymph node metastasis (LNM), as one of the primary metastatic pathways in rectal cancer, is closely associated with disease staging and patient prognosis. Therefore, accurate assessment of lymph node status is critical for guiding clinical management. The current National Comprehensive Cancer Network guidelines recommend MRI for assessing lymph node status in patients with rectal cancer. However, the diagnostic accuracy of conventional MRI morphological features in identifying LNM remains suboptimal and insufficient to meet clinical demands for precision diagnosis and treatment of rectal cancer. Emerging functional MRI techniques and artificial intelligence demonstrate considerable potential in enhancing predictive capabilities for lymph node evaluation, yet a comprehensive review of recent advances in these fields is still lacking. This review systematically examines the metastatic pathways of lymph nodes, conventional and functional MRI techniques, and artificial intelligence applications in lymph node assessment in rectal cancer. It aims to provide readers with insights into current assessment approaches and future directions. We suggest that future studies should prioritize the discovery of novel morphological biomarkers, refinement of functional MRI techniques and artificial intelligence algorithms, standardization of imaging protocols and diagnostic models, and validation through multi-center studies with large-scale rectal cancer MRI databases. These advancements may accelerate the clinical translation of diagnostic tools, ultimately aiding clinicians in achieving precise diagnosis of LNM and tailoring personalized therapeutic strategies for rectal cancer patients. ]]></description>
<pubDate>Sun,20 Jul 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Advances in artificial intelligence research in prostate cancer]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.07.031</link>
<description><![CDATA[Prostate cancer (PCa) has the second highest incidence of malignant tumors among men worldwide, and its precise diagnosis and treatment decision-making urgently needs more accurate auxiliary tools. The rise of artificial intelligence (AI) technology has brought unprecedented opportunities for early diagnosis and precision treatment of PCa. This paper provides a systematic review of the current state of AI in three core areas of prostate cancer: (1) Diagnosis and prognosis assessment, we review the current status of the application of traditional PCa diagnostic tools and focus on the progress of the application of AI in multimodal imaging technology; (2) Molecular mechanism research, we explore the application model of AI in genomics, proteomics and other high-throughput genomics data, revealing key molecular mechanisms of disease development; (3) Treatment decision optimization, we illustrate the innovative practice of AI in surgical planning and intraoperative navigation, personalized design of targeted treatment protocols, and postoperative dynamic monitoring, highlighting the potential value of AI in improving outcomes and reducing and minimizing the risk of complications. This paper describes clinical-grade PCa-specific AI systems and analyzes their advantages in improving the efficiency and accuracy of diagnosis and treatment. Aiming at the challenges faced by AI in PCa applications, such as single data source, insufficient model generalization ability, "black box" characteristics, and lack of multimodal data standardization, future research should focus on building cross-center, multimodal standardized databases and introducing privacy computing technology applications such as federated learning; developing interpretable AI frameworks to enhance clinical trust; and continuously optimizing algorithmic performance to improve the utility and reliability of models. The purpose of this review is to summarize the latest advances and challenges in the application of AI in the field of PCa, and to provide guidance for future research directions in order to promote the deep integration of AI technology with PCa clinical research and practice. ]]></description>
<pubDate>Sun,20 Jul 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress of MRI in the evaluation of sacroiliac joint structural lesions in axial spondyloarthritis]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.07.032</link>
<description><![CDATA[Axial spondyloarthritis (axSpA) has the characteristics of high prevalence, long course of disease and high disability rate. It is easy to involve sacroiliac joints (SIJ), which is manifested as active and structural lesions of SIJ. The 2019 Assessment of Spondylo Arthritis International Society (ASAS) updated the specific magnetic resonance imaging (MRI) findings of axSpA patients on SIJ, emphasizing the principle of equal emphasis on active lesions and structural lesions. According to the ASAS MRI classification criteria, this paper reviews the methods of detecting and evaluating the MRI signs of axSpA structural lesions in recent years, and provides new detection and evaluation ideas for the early diagnosis of SIJ structural lesions in clinical axSpA patients, which is helpful to improve the accuracy of the diagnosis of the disease. ]]></description>
<pubDate>Sun,20 Jul 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Advances in magnetic resonance imaging for the assessment of sarcopenia]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.07.033</link>
<description><![CDATA[Sarcopenia, a prevalent degenerative syndrome in the elderly population, is characterized by progressive declines in skeletal muscle mass, muscle strength, and physical function. Its pathogenesis involves multiple pathophysiological factors, including disrupted proteostasis, mitochondrial dysfunction, and chronic low-grade inflammation, ultimately leading to impaired physical capacity and loss of independence. Current literature demonstrates that magnetic resonance imaging (MRI), with its advantages of non-invasiveness, high soft-tissue resolution, and multiparametric quantitative analysis capabilities, has emerged as a pivotal imaging modality for investigating sarcopenia pathology and clinical assessment. Utilizing techniques such as basic structural sequences, quantitative mapping techniques, and advanced functional MRI (fMRI) techniques, MRI provides critical insights. Multiple studies confirm that MRI-derived muscle metrics serve as independent predictors for adverse outcomes including frailty and postoperative complications in older adults. However, limitations persist in MRI-based sarcopenia evaluation, notably the lack of standardized protocols and underutilization of advanced fMRI. Future research should prioritize developing integrated multimodal imaging frameworks, combining quantitative MRI with radiomics analysis. This review systematically elaborates on the pathobiology of sarcopenia and provides an in-depth analysis of MRI applications in muscle morphometry, compositional quantification, and functional evaluation, aiming to advance clinical diagnosis and therapeutic strategies. ]]></description>
<pubDate>Sun,20 Jul 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress of blood oxygenation level dependent magnetic resonance imaging in assessing tumor hypoxia]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.07.034</link>
<description><![CDATA[Hypoxia is a critical feature of most solid tumors, which induces aggressive and therapy-resistant tumor phenotypes, leading to rapid tumor progression and poor prognosis. Therefore, accurate assessment of tumor hypoxia holds significant importance for guiding treatment decisions, predicting therapeutic outcomes, and developing targeted therapeutic interventions. Blood oxygen level-dependent magnetic resonance imaging (BOLD-MRI) evaluates deoxyhemoglobin content in tissues by quantifying the effective transverse relaxation time (T2<sup>*</sup>) and effective transverse relaxation rate (R2<sup>*</sup>), thereby indirectly reflecting tumor oxygenation status. As one of the MRI functional imaging methods for assessing tumor hypoxia, it offers advantages in non-invasive comprehensive assessment of tumor oxygenation and monitoring its dynamic changes. In recent years, the emergence of quantitative BOLD-MRI (qBOLD-MRI) technology has achieved a technological leap from indirect to direct evaluation of tissue oxygenation, enabling more precise capture of tumor oxygen metabolism-related information and further expanding the application prospects of BOLD-MRI. This article comprehensively reviews research advances in quantitative assessment of tumor hypoxia by BOLD-MRI and qBOLD-MRI, explores research prospects and future directions, and aims to provide evidence for developing personalized tumor treatment strategies. ]]></description>
<pubDate>Sun,20 Jul 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Clinical application progress of magnetic resonance golden angle radial sparse parallel technique]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.07.035</link>
<description><![CDATA[The golden-angle radial sparse parallel (GRASP) technique is a new dynamic contrast-enhanced magnetic resonance imaging technology that integrates compressed sensing, parallel imaging, and golden-angle radial sampling. It can accelerate imaging speed while obtaining high spatial resolution image information. Moreover, it allows for post-reconstruction processing of the acquired raw data to reduce the impact of artifacts caused by respiratory motion, thereby ensuring image quality. The GRASP technique has been preliminarily applied in cardiovascular imaging, abdominal dynamic imaging, and tumor diagnosis, achieving higher diagnostic accuracy compared with traditional imaging methods. This article will provide a systematic review of the basic principles of GRASP technology, its clinical application progress in multiple areas such as the head and neck, cardiovascular system, chest and abdomen, and motor system, and explore its latest expanded technologies. The aim is to provide a new perspective for the future improvement of this technology and promote its clinical application, providing reference for clinical diagnosis and treatment plans of diseases. ]]></description>
<pubDate>Sun,20 Jul 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress of synthetic MRI in clinical diseases]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.07.036</link>
<description><![CDATA[Synthetic MRI (SyMRI) is an emerging quantitative MRI technique that can obtain multi-contrast images through a single scan, achieving equivalent diagnostic efficacy to traditional MRI. In recent years, SyMRI technology has become increasingly mature, with continuously improving image quality. Its application has expanded to various parts of the body, including the central nervous system, breast, musculoskeletal system, ovary, rectum and prostate. The prominent advantage of SyMRI lies in its ability to break through the traditional reliance of MRI on multiple sequence scans, significantly reducing the scanning time. It measures the inherent characteristics of tissues based on quantitative sequences and enables quantitative comparison of tissue parameters. This article reviews the basic principles, feasibility verification and image quality evaluation, as well as clinical applications of SyMRI, aiming to expand new examination ideas for the precise diagnosis and treatment of diseases in various systems. ]]></description>
<pubDate>Sun,20 Jul 2025 00:00:00  GMT</pubDate>
</item>
</channel>
</rss>
